5-Heptenoic acid, 7-[(1R,2R,3R,5S)-2-[(1E)-3,3-difluoro-4-phenoxy-1-buten-1-yl]-3,5-dihydroxycyclopentyl]-, ethyl ester, (5Z)- - Names and Identifiers
5-Heptenoic acid, 7-[(1R,2R,3R,5S)-2-[(1E)-3,3-difluoro-4-phenoxy-1-buten-1-yl]-3,5-dihydroxycyclopentyl]-, ethyl ester, (5Z)- - Physico-chemical Properties
Molecular Formula | C24H32F2O5
|
Molar Mass | 438.5 |
Density | 1.202±0.06 g/cm3(Predicted) |
Boling Point | 546.6±50.0 °C(Predicted) |
pKa | 14.48±0.70(Predicted) |
Storage Condition | − 20 ℃, closed, dry |
5-Heptenoic acid, 7-[(1R,2R,3R,5S)-2-[(1E)-3,3-difluoro-4-phenoxy-1-buten-1-yl]-3,5-dihydroxycyclopentyl]-, ethyl ester, (5Z)- - Introduction
Tafluprost ethyl ester is a synthetic natural prostaglandin-like compound that has the effect of reducing pressure in the eye. It is a colorless to slightly yellow oily liquid, soluble in organic solvents.
Tafluprost ethyl ester is mainly used to treat glaucoma and ocular hypertension. It reduces intraocular pressure by reducing aqueous humor production and increasing aqueous humor drainage. It can be used in the form of eye drops once a day.
Tafluprost ethyl ester is prepared mainly by reacting specific compounds with fluoroacetic anhydride to generate Tafluprost ethyl ester. During the preparation process, attention should be paid to the operating conditions and purity control to ensure the quality of the product.
For safety information, use of Tafluprost ethyl ester may cause some eye discomfort, such as irritation, pain, or itching. Some people may also experience adverse reactions such as blurred vision, dry eyes or red eyes. In addition, Tafluprost ethyl ester may cause allergic reactions in some people. Therefore, consult a doctor before use and use according to the doctor's instructions.
Last Update:2024-04-09 20:52:54